Fagron has acquired Central de drogas (Cedrosa)

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Central de drogas (Cedrosa)
Mexico
Advisor to the seller
Healthcare & Pharmaceuticals
414Capital-RIóN

The belgian group Fagron acquired CEDROSA, a leading supplier of raw materials (essentials) to the pharmaceutical and other industries in Mexico.

Central de drogas (Cedrosa)
Fagron
Sale of Cedrosa, supplier of raw materials to the pharmaceutical industries in Mexico, to the Belgian group Fagron
logo
Advisor to the seller :
414Capital-RIóN

Experts who worked on this transaction

Alexander von Griesheim

Alexander von Griesheim

REACH Operational Committee member Partner at 414Capital-RIóN

Eugenio Fernandez

Eugenio Fernandez

Partner at 414Capital-RIóN

Relevant transactions

Transactions
United States Drug Testing Laboratories Inc.
Northlane Capital Partners
United States Drug Testing Laboratories Inc. acquired by Northlane Capital Partners.
logo
Advisor to the seller :
Brown Gibbons Lang & Company
Project Amygdala
Private Equity
Sale of mental health services provider for high-acuity individuals in the UK
logo
Advisor to the seller :
Cooper Parry Corporate Finance
Genbio
Private Investors
Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors
logo
Advisor to the seller :
414Capital-RIóN
icotec
MVM Partners
icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM
logo
Advisor

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2025 REACH Cross-Border Mergers & Acquisitions